NO972046L - Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike - Google Patents

Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike

Info

Publication number
NO972046L
NO972046L NO972046A NO972046A NO972046L NO 972046 L NO972046 L NO 972046L NO 972046 A NO972046 A NO 972046A NO 972046 A NO972046 A NO 972046A NO 972046 L NO972046 L NO 972046L
Authority
NO
Norway
Prior art keywords
allogeneic
antibodies
diagnosis
therapy
determining
Prior art date
Application number
NO972046A
Other languages
English (en)
Norwegian (no)
Other versions
NO972046D0 (no
Inventor
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO972046D0 publication Critical patent/NO972046D0/no
Publication of NO972046L publication Critical patent/NO972046L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO972046A 1994-11-04 1997-05-02 Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike NO972046L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002238A IT1276860B1 (it) 1994-11-04 1994-11-04 Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
PCT/EP1995/004239 WO1996014340A1 (en) 1994-11-04 1995-10-30 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Publications (2)

Publication Number Publication Date
NO972046D0 NO972046D0 (no) 1997-05-02
NO972046L true NO972046L (no) 1997-05-02

Family

ID=11369803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972046A NO972046L (no) 1994-11-04 1997-05-02 Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike

Country Status (26)

Country Link
EP (1) EP0789716B1 (ja)
JP (1) JPH10508591A (ja)
KR (1) KR100426029B1 (ja)
CN (1) CN1046737C (ja)
AR (1) AR002243A1 (ja)
AT (1) ATE192166T1 (ja)
AU (1) AU690756B2 (ja)
BR (1) BR9509556A (ja)
CA (1) CA2204380A1 (ja)
CZ (1) CZ288322B6 (ja)
DE (1) DE69516534T2 (ja)
DK (1) DK0789716T3 (ja)
ES (1) ES2147617T3 (ja)
FI (1) FI971879L (ja)
GR (1) GR3033956T3 (ja)
HU (1) HUT76880A (ja)
IL (1) IL115862A (ja)
IT (1) IT1276860B1 (ja)
NO (1) NO972046L (ja)
NZ (1) NZ295171A (ja)
PL (1) PL181115B1 (ja)
PT (1) PT789716E (ja)
RU (1) RU2160445C2 (ja)
TR (1) TR199501353A2 (ja)
WO (1) WO1996014340A1 (ja)
ZA (1) ZA959255B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283634B1 (it) * 1996-05-10 1998-04-23 Zetesis Spa Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
CN100516876C (zh) * 2002-11-21 2009-07-22 惠氏公司 用于诊断肾细胞癌(rcc)和其他实体瘤的方法
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
IT201900022203A1 (it) * 2019-11-26 2021-05-26 Cusani Alberto Bartorelli Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO861491L (no) * 1985-04-22 1986-10-23 Hybritech Inc Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser.
SU1603301A1 (ru) * 1987-12-22 1990-10-30 Карагандинский государственный медицинский институт Способ определени концентрации иммуноглобулинов в биологической жидкости
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.

Also Published As

Publication number Publication date
EP0789716A1 (en) 1997-08-20
TR199501353A2 (tr) 1996-06-21
ZA959255B (en) 1996-05-29
NZ295171A (en) 1998-07-28
AU690756B2 (en) 1998-04-30
CN1166838A (zh) 1997-12-03
CN1046737C (zh) 1999-11-24
IT1276860B1 (it) 1997-11-03
DK0789716T3 (da) 2000-10-09
IL115862A0 (en) 1996-01-31
FI971879A7 (fi) 1997-06-24
GR3033956T3 (en) 2000-11-30
MX9703191A (es) 1997-07-31
ITMI942238A1 (it) 1996-05-04
ATE192166T1 (de) 2000-05-15
KR970707161A (ko) 1997-12-01
HUT76880A (en) 1997-12-29
CZ288322B6 (en) 2001-05-16
AU3845395A (en) 1996-05-31
NO972046D0 (no) 1997-05-02
ES2147617T3 (es) 2000-09-16
DE69516534D1 (de) 2000-05-31
RU2160445C2 (ru) 2000-12-10
PL319878A1 (en) 1997-09-01
KR100426029B1 (ko) 2004-07-31
DE69516534T2 (de) 2000-11-30
ITMI942238A0 (it) 1994-11-04
FI971879L (fi) 1997-06-24
PT789716E (pt) 2000-09-29
WO1996014340A1 (en) 1996-05-17
BR9509556A (pt) 1997-09-16
JPH10508591A (ja) 1998-08-25
PL181115B1 (pl) 2001-05-31
EP0789716B1 (en) 2000-04-26
FI971879A0 (fi) 1997-05-02
IL115862A (en) 2001-06-14
CA2204380A1 (en) 1996-05-17
CZ131497A3 (en) 1997-12-17
AR002243A1 (es) 1998-03-11

Similar Documents

Publication Publication Date Title
NO973447L (no) Monoklonale antistoffer som er spesifikke for forskjellige epitoper i human-gp 39, og fremgangsmåter for deres anvendelse i diagnose og terapi
TR199501021A2 (tr) Vücut agirligi modülatörüne tekabül eden nükleik asitler ve proteinler ve bunlarin diagnostik ve terapötik kullanimlari.
FI882746A7 (fi) Hybridiproteiini C ja menetelmä sen valmistamiseksi.
DE68905313D1 (de) Enzym-immunoassay zur messung des cyclosporin-a-spiegels in vollblut-proben.
SE9604815D0 (sv) A metod of diagnosis
DE68917273D1 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
FI850051A7 (fi) Virusantigeeni, menetelmä sen talteenottamiseksi ja käyttämiseksi diag noosissa ja terapiassa.
FI883351A7 (fi) Diagnostinen menetelmä häiriöiden toteamiseksi RNA-aasi L:ssä
FI840611A7 (fi) Taudinmääritysaine, menetelmä sen valmistamiseksi ja sen käyttö taudinmääritysmenetelmissä.
NO872881D0 (no) Fremgangsmaate for bestemmelse av skjult blad i proever fra mennesker.
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
NO972046D0 (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
ES2018143A4 (es) Detector de fuga en refrigerante manual ultrasonico.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
AU7732887A (en) Antibodies for use in determining human glycoalbumin
IT1274006B (it) Saggio immunologico per analiti in campioni, che utilizza agenti alchilanti
FI903964A7 (fi) Menetelmä vasta-aineiden havaitsemiseksi verestä, ja menetelmässä käyt ettävä membraaniliuska ja membraanikalusto
IT1279079B1 (it) Vibratore,in particolare per laboratorio dentistico
NO157437C (no) Proeveinnretning for bestemmelse av blod i faeces.
KR890001443U (ko) 플로피 디스크 드라이브의 디스크 안착장치
KR890011591U (ko) 플로피 디스크 드라이브의 디스크 안착장치
FI903637A7 (fi) Diagnostisia analyysimenetelmiä ja niiden käyttö kliinisten tilojen määrittämiseen
SE8600543D0 (sv) Diagnostiskt test for detektering av antikroppar i kroppsvetskor
BR6300998U (pt) Disposicao introduzida em sistema para coleta de sangue
NO863774D0 (no) Boelgedemper med flyte-element innebygget i konstruksjon.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application